Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changes in Antibacterial Therapy Based on Perioperative Dynamics of Presepsin During Reconstructive Thoracic Aorta Surgery
NCT06336213Recruiting
- Sponsor
- Petrovsky National Research Centre of Surgery
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ampicillin + sulbactam in post-operative infection (2 arms), sponsored by Petrovsky National Research Centre of Surgery. Primary endpoint: Infectious complications rate at 10 days. Started Jan 2024; status: recruiting.
02
Drugs
ampicillin + sulbactam
03
Conditions
post-operative infection
Beyond the preview
Go deeper on NCT06336213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06336213.